Skip to main content
Skip to content
EFTA Document EFTA01447081EFTA Document EFTA01447083
Case File
sd-10-EFTA01447082Dept. of JusticeOther

EFTA Document EFTA01447082

Gilead required to give briefing by 03-Apr Sovaldi expected to generate >S4bn in sales this year The drug's expense might saddle state Medicaid programs with steep costs The whole sector is as risk uS is the only major health-care market remaining without any meaningful drug price controls • Risk for the whole sector once the Congress gets involved, especially if focused primarily on pricing The biggest NBI firms sold-off significantly (Embedded image moved to file: pic04781.gif) ways

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01447082
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

Gilead required to give briefing by 03-Apr Sovaldi expected to generate >S4bn in sales this year The drug's expense might saddle state Medicaid programs with steep costs The whole sector is as risk uS is the only major health-care market remaining without any meaningful drug price controls • Risk for the whole sector once the Congress gets involved, especially if focused primarily on pricing The biggest NBI firms sold-off significantly (Embedded image moved to file: pic04781.gif) ways

Download Original PDFSave PDF

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
Gilead required to give briefing by 03-Apr Sovaldi expected to generate >S4bn in sales this year The drug's expense might saddle state Medicaid programs with steep costs The whole sector is as risk uS is the only major health-care market remaining without any meaningful drug price controls • Risk for the whole sector once the Congress gets involved, especially if focused primarily on pricing The biggest NBI firms sold-off significantly (Embedded image moved to file: pic04781.gif) ways to hedge exposure to the us biotech sector ProShares ultraShort Nasdaq Biotech Fund (BIS uS Equity): designed to be 2x short the NBI • options on isharesNasdaq Biotech ETF (IBB us Equity) NBI - last S years (Embedded image moved to file: pic03702.gif) NBI vs S&PS00 - last 1 year (Embedded image moved to file: pic22797.gif) NBI - last 1 year (Embedded image moved to file: pic1795S.gif) KCP Capital Markets This e-mail may contain confidential and/or privileged information. If you are not the intended recipient (or have received this e-mail in error) please notify the sender immediately and destroy this e-mail. Any unauthorized copying, disclosure or distribution of the material in this e-mail is strictly forbidden. (Embedded image moved to file: pic17473.gif) Tazia Smith Director I Key Client Partners - US Deutsche Bank Securities Inc Deutsche Asset & wealth Management 345 Park Avenue, 26th Floor New York. NY 10154 Tel. Fax Mobile Email (Embedded image moved to file: pic13811.gif) CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 101587 CONFIDENTIAL SDNY_GM_00247771 EFTA01447082

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01461474

Nasdaq Biotech Index (NBI) dropped 4.4% Friday Sharpest decline since Oct-11 • Triggered by a letter from congressional representatives to a biotech company Gilead Sciences, questioning its plans to sell a hepatitis C drug (named Sovaldi) for 584,000 per dose Gilead required to give briefing by 03-Apr • Sovaldi expected to generate >S4bn in sales this year The drug's expense might saddle state Medicaid programs with steep Costs The whole sector is as risk us is the only major health-

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01468772

Subject: Fw: Copper - positive momentum from China cap mkts reform From: Tazia Smith <M > Date: Mon, 12 Ma 2014 17:01:03 -0400 To: Cc: Vahe Stepanian < Paul Morris < Rich- Copper faded only slightly - mid on Dec 7000 call is $251. morning. Thus Jeffrey's option mid is Using same vol spread (0.6%) this morning. TDS 6875 vs. 6883 spot ref this morning (LPZ4 6836) 72 at the end of the day, vs. $252/mt this $314,650 mid, vs. $315,000 mid this morning. the EOD indicative bid $299,448

11p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01468814

Subject: Copper EOD 5/13/14... From: Tazia Smith Date: Tue, 13 Ma 2014 15:25:05 -0400 To: Cc: Paul Morris < Vahe Stepanian < Rich - End of the day (EOD) on the copper call - December copper was down, 6808 on LPZ4 vs. 6836 yesterday. mid on Dec 7000 call is $237/mt vs. $251.72/mt yesterday Thus Jeffrey's option mid is $296,250 mid, vs. $314,650 mid yesterday Using same vol spread (0.6%) and vega (20.27) the EOD indicative bid $281,250 vs. $299,448 this morning. Tazia From: dbcom T

12p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01452764

From: Paul Morris Sent: 2/28/2014 6:07:56 AM To: Tazia Smith CC: Vahe Stepanian Subject: Re: follow-up call [C] ; Paul Morris ; Vinit Sahni [ ; Nay Gupta Classification: Confidential No, vinit are u available this morning? Original Message From: Tazia Smith Sent: 02/27/2014 10:57 PM EST To: Paul Morris Cc: Vahe Stepanian; Vinit Sahni ; Nay Gupta Subject: Re: follow-up call [C] Classification: Confidential Is this call confirmed? Tazia Smith Director Key Client Partne

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01461493

Bookrunners: JPMorgan Morgan Stanley Deutsche Bank Co-managers: Jefferies Stifel William Blair The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01453366

European Digital on USD/RUB Strike: 37.55 Payout: USD 1,000,000 Payout Ccy: USD Expiry: Fri 11-Apr-2014 Settlement: Mon 14-Apr-2014 ZoneCut: MO Premium: USD 255,000 Premium Date: Fri 14-Mar-2014 This Digital pays the owner USD 1,000,000 if USDRUB is above 37.55 at the time of expiry. Tazia Smith Director Key Client Partners - US Deutsche Bank Securities, Inc. Deutsche Asset & Wealth Management 345 Park Avenue - 26th Floor New York, NY 10154 Te M - From: Jeffrey Epstein fieevac

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

DonateMore ways to support →
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.